Deputy General Manager,

Master of Organic Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, has long been engaged in API R & D and industrialization. successfully developed and transformed Ezetimibe, Ticagrelor, Cigarene, Engelcoze, LCZ696 , Parecoxib sodium and other more than ten varieties of research and development and industrialization. Study and familiar with generic drug registration declaration, the relevant state laws and regulations. Has many years of R&D management experience.